The founding partners of the Lung Ambition Alliance launched the group July 8 with the primary objective of doubling five-year survival rates for patients with lung cancer—up to 40%.
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
